Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

The purpose of this study is to assess the prevalence and predictors of pituitary dysfunction, as well as secondary out-come in patients with traumatic brain injury or spontaneous subarachnoidal haemorrhages.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Brain Injuries Aneurysm Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Craniocerebral Trauma Intracranial Aneurysm Intracranial Arterial Diseases Nervous System Diseases Trauma, Nervous System Vascular Diseases Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Endocrinology PE2131, Copenhagen University Hospital, Rigshospitalet

Copenhagen, DK-2100, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of traumatic brain injury (TBI) or subarachnoidal haemorrhages (SAH)

Exclusion criteria

Alcohol or drug abuse
Prior TBI or SAH
Chronic use of glucocorticoids
Pregnancy or breast feeding
Diagnosis of psychiatric diseases or malignant neoplasms

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Collaborators

AP Moeller Foundation
Novo Nordisk A/S
University of Copenhagen

Registry information

Important dates

Study start: 2003
Study completion: 2006
First posted: Feb 14, 2007
Registry last updated: Feb 14, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed